Dr Laura Waters
@drlaurajwaters.bsky.social
NHS GUM/HIV doc @CNWLNHS | Honorary Assoc Professor @UCLGlobalHealth | @peoplefirstcharter@bsky.social founder | ex BHIVA chair | NSA HIV @NHSEngland | @RCPhysicians PIO | BASHH patient & public panel chair | she/her | @iasociety GC | Campari | Humanism
Linda Gail Bekker highlighted the critical importance of oral loading with lenacapavir. Missing it significantly delays (to 28 days) the time taken to achieve target concentrations which are reached by day 2 with loading #IAS2025 @iasociety.bsky.social
In our latest episode of The Future of HIV Care on TheBodyPro, @drlaurajwaters.bsky.social and I share what's on our minds about lenacapavir PrEP approval in the U.S., the growing concern about the future of U.S. HIV clinical guidelines, and... goats. www.thebodypro.com/podcast/hiv/...
The Future of PrEP—and HIV Guidelines Under Threat
A discussion about what comes next following the U.S. approval of lenacapavir PrEP, and about growing concerns for the future of HIV clinical guidelines within the U.S.
thebodypro.com
Impact of PEPFAR cuts on HIV care in Mozambique #IAS2025 with 3rd highest no of PWH & 2nd highest new diagnoses, 67% of funding from PEPFAR in 2022. - 14% reduction in ART initiations - 39% increase in ART interruption - reduced VL testing & viral suppression, esp children @iasociety.bsky.social
#IAS2025 first ever lenacapavir PrEP implementation study will be in Brazil! Will include a mobile PrEP unit in Sao Paolo to best reach communities who will benefit @iasociety.bsky.social
At the IAS members meeting with a wondrous panel (see pic). I'm finding the discussions about funding & the struggles people experience trying to fund their attendance really emotive. This will be increasingly challenging in the future & I wish I had a solution #ias2025
The much anticipated DO-IT trial shows no impact of switch from TAF + INSTI to DOR (with TAF or TDF) on weight in people with obesity. Considering switching ART only to address weight change? DON'T DO-IT..... #IAS2025 @iasociety.bsky.social
The TECAIN Study (tricholoacetic acid vs electrocautery for AIN treatment in people with HIV) at 24W showed TCA non-inferior to ECA. #IAS2027 @iasociety.bsky.social @tristanjbarber.bsky.social
IMPALA results at #IAS2025 1 incident HBV infection in the CAB/RPV arm No evidence of HBV reactivation (note people with detectable cAb but sAb <10 were excluded) @iasociety.bsky.social @profchloeorkin.bsky.social @tristanjbarber.bsky.social
Rosemary Mburu #ias2025 "Science is not just data! It is DIGNITY. Investment in people is not just nice to have, it's creating powerful agents for change. RESILIENCE MUST BE MET WITH RESPECT @iasociety.bsky.social
Beatriz Grinszetjn Opens #ias2025! While she can't provide a recipe for success in current climate, there are key factors 1. EVIDENCE 2. SOLIDARITY 3. TRUTH Let us make the most of our time together at the conference to "reaffirm, refocus & rebuild!" @iasociety.bsky.social
New @who.int postnatal prophylaxis guidelines : Infants at ow-risk - preferred: 6W NVP for 6W - alternative: DTG or 3TC for 6W Infants at high-risk - ABC + 3TC + DTG for 6W - plus extended PNP during breastfeeding (nevirapine preferred, DTG or 3TC alternatives) #IAS2025 @iasociety.bsky.social
New World Health Organization guidelines recommend darunavir as preferred PI and new appearance for LA-CAB/RPV as a switch option for people who are virally suppressed. #IAS2027 @iasociety.bsky.social @who.int @tristanjbarber.bsky.social
@who.int guidelines launch at #IAS2025 includes the just released guidelines on LEN PrEP including recommendation to use HIV rapid tests, NAAT too slow & expensive.... iris.who.int/bitstream/ha... @tristanjbarber.bsky.social
Mitchell Warren of AVAC shares data, based on many assumptions, of potential injectable PrEP use in 2026 based on 2024 oral uptake & preference data. And the ways forward.....prioritise, prioritise, prioritise (sorry, I changed the spelling 😘) #IAS2025
We are at an absolutely critical point in the HIV response which is why the @iasociety.bsky.social conference in Kigali so so very important. And when LISTENING is more important than ever, the live translation feature for the main sessions is particularly welcome....well done IAS #IAS2025
📢 BASHH has today published national clinical guidelines on the use of doxyPEP. This makes the UK one of the first countries globally to offer formal clinical direction on this STI prevention strategy. 🔗 Read our full statement & access the guidelines: bit.ly/4475DDK
Outstanding presentation on gender affirming care for adults in the UK from Alison Berner #bashh2025 The 2 screenshots provide invaluable advice, & until new NHSE guidance is produced, the 2019 advice applies @bashhuk.bsky.social
What happens when you throw @paulsaxmd.bsky.social, @drlaurajwaters.bsky.social, Monica Gandhi, and David Wohl into a (virtual) room together and ask them to talk about anal cancer screening guidelines in HIV care? Weird question to ask, but I've got the answer. www.thebodypro.com/video/hiv/an...
Have Anal Cancer Screening Guidelines Gone Too Far?
A panel of expert HIV clinician-researchers discusses the practical challenges of implementing current anal cancer screening guidelines, as well as alternative approaches to identify those at highest ...
thebodypro.com
Fast-Track Cities is a partnership working towards zero new #HIV infections, zero deaths and zero stigma before 2030. For #TeamTuesday meet Dr Laura Waters, HIV National Specialty Advisor and member of our leadership team https://fasttrackcities.london/team/laura-waters/ @drlaurajwaters.bsky.social
Dr Laura Waters - Fast-Track Cities London
Laura Waters is an HIV & Sexual Health consultant at The Mortimer Market Centre, London. She is the National Specialty Advisor for HIV, chairing the group that advises NHS England on HIV treatment and the immediate past chair of the...
fasttrackcities.london
Volunteers wanted! , Are you a sexually active woman who might benefit from #PrEP ? @profygilleece.bsky.social @profchloeorkin.bsky.social @drlaurajwaters.bsky.social @drrageshri.bsky.social @savinglives.bsky.social www.bbc.co.uk/news/article...
Women offered jabs in HIV prevention trial
Project leaders are looking for participants in Birmingham, Manchester, London and Brighton.
bbc.co.uk
The Birmingham AIDS & HIV Memorial Legacy Project 'Cover Up Quilts' are on display at #BHIVA25. Come & meet the Project Lead, Garry Jones and see several quilts made by people living with #HIV. This project was part funded by the @bhiva.bsky.social @drlaurajwaters.bsky.social community fund.
Huge congratulations to my dearest friend & colleague @tristanjbarber.bsky.social who will be the new @bhiva.bsky.social chair from November!!!! Wise & stylish shoes to fill but I'm sure @profygilleece.bsky.social is delighted it's your feet next 😘😘😘😘
Totally thrilled to be working with @drlaurajwaters.bsky.social and Dr. Magnus Gisslen again to summarize the top studies from #CROI2025. #IDSky #HIVSky Please sign up to join us! 31 March, 2025 medevents.se/events/ch2-2025
The Gilead press release (scroll down to "landmark"): www.gilead.com/news/news-de...
@brendacrabtreer.bsky.social makes excellent point in excellent closing session on INSTI resistance. We should talk about 'INSTI resistance' not 'DTG resistance'. Some LMIC have bictegravir too you know....! And much INSTI resistance is due to prior exposure to 1st generation INSTI too.... #CROI2025
💯 this. We need to *lead* people! #CROI2025
Dr Laura Waters@drlaurajwaters.bsky.social · last yr.FFFS. Maybe I'm just particularly grumpy & tired today but stop saying that PEOPLE FAILED. Their treatment failed. Especially when they are on injectables and had all their injections on time. I'm literally flinching each time I hear it. @peoplefirstcharter.bsky.social #CROI2025
FFFS. Maybe I'm just particularly grumpy & tired today but stop saying that PEOPLE FAILED. Their treatment failed. Especially when they are on injectables and had all their injections on time. I'm literally flinching each time I hear it. @peoplefirstcharter.bsky.social #CROI2025
Sobering talk from an excellent Jeremy Nel on global implications of INSTI resistance. "Nuisance for HIC but profound challenges for LMIC" - so true #CROI2025
